Releases
-
Dexmedetomidine and delirium
The sedative dexmedetomidine, when administered during or after heart surgery, is associated with postoperative delirium and adverse outcomes. Read MoreJun 21, 2021
-
COVID-19 complication underdiagnosed
A mysterious inflammatory syndrome linked to COVID-19 infection and first identified in children also occurs in adults, Vanderbilt researchers report. Read MoreJun 17, 2021
-
Vanderbilt researcher finds that Supreme Court ban on race-conscious college admissions would restrict the pipeline of future leaders
Affirmative action admissions policies admit diverse students, who are then recruited to elite professions and C-suite leadership, according to new research by law and economics professor Joni Hersch. Read MoreJun 10, 2021
-
Heat for hypertension in autonomic failure
Heat therapy could offer a novel nonpharmacologic approach for treating the overnight hypertension that affects patients with autonomic failure. Read MoreMay 25, 2021
-
Analysis reveals macrophages associated with kidney cancer recurrence
A white blood cell, the TREM2/APOE/C1Q-positive macrophage, has been identified as a potential biomarker to predict recurrence of the most common type of kidney cancer and as a possible target for drug development. Read MoreMay 24, 2021
-
Therapeutic antibodies for hantavirus
Vanderbilt Vaccine Center researchers have isolated monoclonal antibodies against hantaviruses, an emerging source of human disease with pandemic potential. Read MoreMay 24, 2021
-
New clue to lung scarring
Vanderbilt neonatology team pinpoints signaling pathways involved in the progressive lung fibrosis that occurs in rare genetic diseases. Read MoreMay 20, 2021
-
Beta cell regeneration
Vanderbilt researchers dissected the complex microenvironment of the pancreatic islet to discover the signals that drive beta cell regeneration — as a possible treatment for diabetes. Read MoreMay 20, 2021
-
Ask an Expert: Why is it important for women to seek preventative care during the pandemic?
Vanderbilt School of Nursing assistant professor of nursing Melissa Davis discusses why it is important for women to seek preventative care during the pandemic. Read MoreMay 14, 2021
-
People at high genetic risk for colorectal cancer benefit more from lifestyle changes
People with a high polygenic risk score for colorectal cancer could benefit more at preventing the disease by leading healthy lifestyles than those at lower genetic risk, according to a study by Vanderbilt researchers published in the April issue of The American Journal of Clinical Nutrition. Read MoreMay 13, 2021
-
Vanderbilt Divinity School to host screening of ‘Far East Deep South’
Vanderbilt Divinity School will host the third part of a series exploring the realities of the Asian and Asian American diaspora on May 12 the with a 6 p.m. CT film screening and talkback about the documentary film "Far East Deep South." Read MoreMay 12, 2021
-
Personalized Structural Biology aids cancer treatment decisions
Cancer specialists at Vanderbilt University Medical Center, in partnership with biochemists and structural biologists across the Vanderbilt University campus, are taking “personalized” cancer therapy to a new level. Read MoreMay 8, 2021
-
Study revises understanding of cancer metabolism
Tumors consume glucose at high rates, but a team of Vanderbilt researchers has discovered that cancer cells themselves are not the culprit, upending models of cancer metabolism that have been developed and refined over the last 100 years. Read MoreMay 8, 2021
-
VUMC to lead national study to treat severe COVID complications
The Vanderbilt Institute for Clinical and Translational Research (VICTR) has been awarded a major federal grant to lead a national trial of treatments targeting the Renin Angiotensin Aldosterone System (RAAS) in patients hospitalized with COVID-19. Read MoreMay 6, 2021
-
Study finds that regulatory protein prevents signaling that triggers cell death
A protein implicated in neurodegenerative diseases including amyotrophic lateral sclerosis prevents the activation of an innate immune response that leads to cell death, Vanderbilt researchers have discovered. Read MoreMay 6, 2021
-
New strategy to treat brain bleeding
Vasorelaxing peptides could offer a promising therapeutic strategy for reducing the neurological deficits caused by subarachnoid hemorrhage-induced cerebral blood vessel constriction. Read MoreMay 4, 2021
-
Strength in numbers
Voluntary data sharing across a region’s health systems and ambulatory care practices is important for measuring and improving health care quality and safety, Vanderbilt researchers report. Read MoreMay 3, 2021
-
Vanderbilt researcher explains Pizzly bear hybrid species
Associate Professor of Biological Sciences Larisa DeSantis discusses pizzly bears (grizzy + polar bear hybrid species)! Read MoreApr 20, 2021
-
New therapeutic strategy for leukemia syndrome
Using primary cells from patients with chronic myelomonocytic leukemia, Vanderbilt researchers found synergistic inhibition of cell viability and proliferation, suggesting a new treatment strategy. Read MoreApr 20, 2021
-
VUMC aids national effort to repurpose drugs for COVID-19
Vanderbilt University Medical Center (VUMC) has been named Data Coordinating Center (DCC) for a nationwide platform of studies aimed at “repurposing” existing drugs to treat mild to moderate symptoms of COVID-19. Read MoreApr 19, 2021